Christophe Fruchart

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

Frédéric Peyrade, Fabrice Jardin, Catherine Thiéblemont et al. · The Lancet Oncology · 2011 · 530 citations

Hematological Malignancy, Lymphoid Neoplasia, Autoimmune Disease +8

Hypodiploidy is a major prognostic factor in multiple myeloma

Nicole Smadja, Christian Bastard, Christophe Brigaudeau et al. · Blood · 2001 · 387 citations · Full text

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

Franck Morschhauser, Nathan Fowler, Pierre Feugier et al. · New England Journal of Medicine · 2018 · 357 citations · Full text

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial

Christian Récher, Bertrand Coiffier, Corinne Haïoun et al. · The Lancet · 2011 · 356 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Medicine +8

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial

Richard Delarue, Hervé Tilly, Nicolas Mounier et al. · The Lancet Oncology · 2013 · 298 citations

Hematological Malignancy, Dose-dense Rituximab-chop, Standard Rituximab-chop +6